Song et al., Immunol Lett 2008
(Leukemia) :
In addition, PD98059 ( an ERK1/2 MAPK inhibitor ) and SP600125 ( a JNK inhibitor ) attenuated IL-18 induced ULBP2 expression in a dose dependent manner
Ogbomo et al., Neoplasia (New York, N.Y.) 2008
(Leukemia) :
Furthermore, overexpression of constitutively active ERK in H9 parental cells resulted in increased ULBP-2/ULBP-3 expression and enhanced NK cell lysis
Wu et al., Neoplasia (New York, N.Y.) 2012
(MAP Kinase Signaling System...) :
Activation of constitutively phosphorylated extracellular signal regulated kinase ( ERK ) by VPA is essential for the up-regulation of MICA/B and ULBP2 expressions ... Furthermore, overexpression of constitutively active ERK in ARK resulted in increased MICA/B and ULBP2 expressions and enhanced NK cell lysis